Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
6,531,452
-
Shares change
-
-586,949
-
Total reported value, excl. options
-
$12,668,286
-
Value change
-
-$1,140,536
-
Number of buys
-
5
-
Number of sells
-
-12
-
Price
-
$1.94
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q3 2016
25 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q3 2016.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,531,452 shares
.
Largest 10 shareholders include Abingworth LLP (1,600,000 shares), Versant Venture Management, LLC (1,048,601 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (958,822 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (700,000 shares), Lombard Odier Asset Management (USA) Corp (626,978 shares), VANGUARD GROUP INC (614,705 shares), Omega Fund Management, LLC (301,477 shares), ALLIANCEBERNSTEIN L.P. (210,731 shares), RENAISSANCE TECHNOLOGIES LLC (120,800 shares), and GEODE CAPITAL MANAGEMENT, LLC (98,296 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.